← 產業報告目錄

Postbiotics Market by Source (Bacteria, Yeast), Application (Functional Food & Beverages, Dietary Supplements, Animal Feed, Cosmetics & Personal Care, and Pharmaceuticals), Form, Function, Manufacturing Technology, and Region - Global Forecast to 2030

出版商 MarketsandMarkets產業別 Food & Beverage出版日期 2025-07-29頁數 270報告編號 FB9502

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The postbiotics market is estimated at USD 146.7 million in 2025 and is projected to reach USD 224.8 million by 2030, at a CAGR of 8.9%. The global postbiotics market is gaining significant traction, driven by increasing consumer awareness of gut health, immune support, and the demand for clean-label, shelf-stable ingredients. The growing demand for functional food & beverage products is also expected to drive the demand for the usage of postbiotic ingredients in these applications. The functional food & beverage sector has witnessed explosive growth, driven by a shift in consumer preferences toward health-enhancing everyday products. Foods fortified with ingredients that support immunity, digestion, energy, and mental clarity are now mainstream, especially in developed markets. Unlike probiotics, which require cold-chain logistics and can lose efficacy under processing conditions, postbiotics are heat-stable and shelf-stable, making them an ideal fit for beverages, high-protein bars, fermented dairy alternatives, and meal replacements. Their proven benefits in gut health and immune modulation allow brands to include science-backed claims on packaging, boosting consumer trust and driving adoption. However, consumers are less familiar with postbiotics compared to probiotics and prebiotics; thus, competition from established alternatives such as probiotics and prebiotics is expected to pose a challenge in the postbiotics market. “Disruptions in the postbiotics market may offer opportunities for players.” The postbiotic ingredients market is being disrupted by the development in microbial science, the shift in regulatory forces, and the growing need for safe & stable health ingredients. Postbiotics, or non-viable microbial cells or their metabolites, are becoming increasingly popular as a next-generation substitute for probiotics because of improved safety, shelf stability, and formulation flexibility. This transformation is especially evident in uses like functional foods, dietary supplements, cosmetics, and pet nutrition, where postbiotics provide distinctive benefits over live probiotics. Advances in fermentation technology and microbial inactivation are enabling developers to create customized, strain-specific postbiotic ingredients that provide specialized health benefits like gut health, immune function, and skin barrier function. The market is also being formed by new formats and blends of products, such as synbiotic products combining probiotics, prebiotics, and postbiotics. Postbiotics are becoming a functional alternative to antibiotic growth promoters in animal nutrition, but in personal care, they are upending conventional actives in microbiome-driven skincare. Thus, the growth of personalized nutrition and microbiome testing is also allowing the creation of postbiotic solutions, further driving market evolution and differentiation. The dietary supplement segment is projected to be one of the fastest-growing segments Dietary supplements are a growing segment that serves the rising demand from consumers for proactive health management and preventive wellness methods. To address various functional benefits or promote general well-being, postbiotic products are designed to offer key advantages over probiotics, such as longer shelf life, no refrigeration requirement, and suitability for sensitive populations like infants and the elderly. Consumer awareness and adoption of preventative health measures are key factors propelling the rise of dietary supplements. In order to preserve optimal health and lower their risk of chronic diseases, many people are turning to supplements as a result of growing emphasis on self-care and rising healthcare costs. As a result, the market for dietary supplements has grown significantly, offering a wide range of offerings that address different health issues. Yeast segment to grow at a significant rate among the sources in the postbiotics market Postbiotics that are sourced from yeast hold a significant opportunity in the animal nutrition industry, particularly in the face of increasing challenges such as pathogen pressure, heat stress, high stocking densities, and the drive to reduce antibiotic use. Yeast-sourced postbiotics offer various health benefits for livestock, such as poultry, aquatic animals, as well as pets. It helps in supporting gut health, improving feed efficiency, and enhancing immunity. Additionally, as the industry is shifting toward natural solutions to maintain animal welfare and productivity, yeast-based postbiotics are gaining traction in terms of usage to improve the overall animal well-being without relying on antibiotics. US to dominate the North American postbiotics market during forecast period The US market is one of the largest global markets for postbiotics. Consumers in the US are becoming increasingly interested in functional food ingredients that provide certain health benefits as preventative healthcare and nutrition gain importance. This need has been driven by factors like an aging population, growing healthcare expenses, and increased awareness of the connection between nutrition and health. Furthermore, producers can now create a broad variety of postbiotic products customized to satisfy a wide range of consumer tastes due to technological improvements and innovations in food processing procedures. These factors are expected to drive the demand for postbiotics in the region. In-depth interviews have been conducted with chief executive officers (CEOs), directors, and other executives from various key organizations operating in the postbiotics market. • By Company Type: Tier 1–25%, Tier 2–45%, and Tier 3–30% • By Designation: CXOs–20%, Managers–50%, Executives–30% • By Region: North America–30%, Europe–25%, Asia Pacific–35%, and Rest of the World–10% Prominent companies in the market include ADM (US), Cargill, Incorporated (US), dsm-firmenich (Netherlands), Kerry Group plc (Ireland), Associated British Foods plc (UK), BASF (Germany), Novozymes A/S, part of Novonesis Group (Denmark), International Flavors & Fragrances Inc (US), MCLS Europe B.V. (Netherlands), Phileo by Lesaffre (France), Lallemand Inc. (Canada), Sami-Sabinsa Group. (India), CJ CheilJedang Corp. (South Korea), Biotenova Sdn. Bhd. (Malaysia), Kirin Holdings Company, Limited (Japan), Bioprox Healthcare (France), MORINAGA MILK INDUSTRY CO., LTD. (Japan), SILAB (France), Probionic Corp (Korea), Nutrignomix Sdn. Bhd. (Malaysia), Stratum Nutrition (US), BBT Biotech GmbH (Germany), and Verdesian Life Sciences (US). Research Coverage This research report categorizes the postbiotics market by source (bacteria and yeast), by application (functional food & beverages, dietary supplements, cosmetics & personal care products, animal feed, and pharmaceutical), by form (dry and liquid), by function (qualitative) (digestive health, gut health, immune health, skin health, heart health, and other functions), by manufacturing technology (qualitative) (heat inactivation, spray drying, lyophilization, fermentation-derived fractionation, cell lysis & supernatant recovery, and encapsulation technologies), and region (North America, Europe, Asia Pacific, and Rest of the World). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of postbiotic ingredients. A thorough analysis of the key industry players has been done to provide insights into their business, services, key strategies, contracts, partnerships, agreements, product launches, mergers & acquisitions, and recent developments associated with the postbiotics market. This report covers the competitive analysis of upcoming startups in the postbiotics market ecosystem. Furthermore, industry-specific trends such as technology analysis, ecosystem & market mapping, and patent & regulatory landscape, among others, are also covered in the study. Reasons to Buy This Report The report offers market leaders/new entrants information on the closest approximations of the revenue numbers for the overall postbiotics and subsegments. It will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities. The report provides insights into the following pointers: • Analysis of key drivers (rising consumer awareness of gut health and overall wellness), restraints (competition from established alternatives such as probiotics and prebiotics), opportunities (technological and economic advantages over probiotics), and challenges (regulatory uncertainty and lack of standardization) influencing the growth of the postbiotics market • Product Development/Innovation: Detailed insights on research & development activities and new product launches in the postbiotics market • Market Development: Comprehensive information about lucrative markets—the report analyzes postbiotics across varied regions • Market Diversification: Exhaustive information about new product sources, untapped geographies, recent developments, and investments in the postbiotics market • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, brand/product comparison, and product footprints of leading players such as ADM (US), Cargill, Incorporated (US), dsm-firmenich (Netherlands), Kerry Group plc (Ireland), Associated British Foods plc (UK), BASF (Germany), Novozymes A/S, part of Novonesis Group (Denmark), International Flavors & Fragrances Inc (US), MCLS Europe B.V. (Netherlands), Phileo by Lesaffre (France), Lallemand Inc. (Canada), Sami-Sabinsa Group. (India), CJ CheilJedang Corp. (South Korea), and other players in the postbiotics market.
目錄 Table of Contents
1 INTRODUCTION 26 1.1 STUDY OBJECTIVES 26 1.2 MARKET DEFINITION 26 1.3 STUDY SCOPE 27 1.3.1 MARKETS COVERED AND REGIONS CONSIDERED 27 1.3.2 INCLUSIONS AND EXCLUSIONS 28 1.3.3 YEARS CONSIDERED 29 1.3.4 CURRENCY CONSIDERED 29 1.3.5 UNITS CONSIDERED 30 1.4 STAKEHOLDERS 30 2 RESEARCH METHODOLOGY 31 2.1 RESEARCH DATA 31 2.1.1 SECONDARY DATA 32 2.1.1.1 Key data from secondary sources 32 2.1.2 PRIMARY DATA 32 2.1.2.1 Key data from primary sources 33 2.1.2.2 Breakdown of primary profiles 33 2.1.2.3 Key insights from industry experts 34 2.2 MARKET SIZE ESTIMATION 34 2.2.1 TOP-DOWN APPROACH 35 2.2.2 SUPPLY-SIDE ANALYSIS 36 2.2.3 BOTTOM-UP APPROACH (DEMAND SIDE) 37 2.3 DATA TRIANGULATION AND MARKET BREAKUP 38 2.4 RESEARCH ASSUMPTIONS 39 2.5 RESEARCH LIMITATIONS AND RISK ASSESSMENT 40 3 EXECUTIVE SUMMARY 41 4 PREMIUM INSIGHTS 45 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN POSTBIOTICS MARKET 45 4.2 NORTH AMERICA: POSTBIOTICS MARKET, BY SOURCE AND COUNTRY 46 4.3 POSTBIOTICS MARKET, BY SOURCE 46 4.4 POSTBIOTICS MARKET, BY FORM 47 4.5 POSTBIOTICS MARKET, BY APPLICATION AND REGION 47 4.6 POSTBIOTICS MARKET: REGIONAL SNAPSHOT 48   5 MARKET OVERVIEW 49 5.1 INTRODUCTION 49 5.2 MACROECONOMIC INDICATORS 49 5.2.1 RISING DEMAND FOR NUTRACEUTICAL AND FUNCTIONAL FOOD 49 5.2.2 SUSTAINABILITY AND CLEAN LABEL TRENDS 50 5.3 MARKET DYNAMICS 51 5.3.1 DRIVERS 52 5.3.1.1 Rising consumer awareness of gut health and overall wellness 52 5.3.1.2 Increasing preference for natural, clean-label ingredients 53 5.3.1.3 Increasing incidence of digestive disorders and chronic health issues 53 5.3.1.4 Growing demand for functional food and beverages 53 5.3.2 RESTRAINTS 54 5.3.2.1 Competition from established alternatives like probiotics and prebiotics 54 5.3.2.2 Unclear clinical recommendations and prescription practices 54 5.3.2.3 Side effects and limited clinical safety data 54 5.3.3 OPPORTUNITIES 55 5.3.3.1 Therapeutic applications in nutrition 55 5.3.3.2 Technological and economic advantages over probiotics 56 5.3.3.3 Emerging applications in food preservation 56 5.3.3.4 Increasing R&D activities for postbiotics 57 5.3.4 CHALLENGES 58 5.3.4.1 Yield optimization, storage, and stability 58 5.3.4.2 Regulatory uncertainty and lack of standardization 59 5.3.4.3 High R&D and production costs 59 5.4 IMPACT OF GEN AI ON FOOD & BEVERAGE INGREDIENTS/ADDITIVES 60 5.4.1 USE OF GEN AI IN FOOD & BEVERAGE INGREDIENTS/ADDITIVES 61 5.4.2 CASE STUDIES FOR GENERATIVE AI IN FOOD & BEVERAGE INGREDIENTS/ADDITIVES 62 5.4.2.1 Kerry Trendspotter leveraged AI and ML to analyze consumer-generated social media content, identifying and predicting food trends 62 5.4.2.2 IFF partners with Salus Optima to create personalized nutrition platform using AI to offer customized dietary recommendations based on metabolic health 62 5.4.2.3 Ingredion utilized cloud-based data analytics, AI, and cloud technology to address challenges in F&B industry 63 5.4.3 IMPACT OF GENERATIVE AI/AI ON POSTBIOTICS MARKET 63 5.4.4 ADJACENT ECOSYSTEM WORKING ON GENERATIVE AI 65   6 INDUSTRY TRENDS 66 6.1 INTRODUCTION 66 6.2 IMPACT OF 2025 US TARIFF – POSTBIOTICS MARKET 66 6.2.1 INTRODUCTION 66 6.2.2 KEY TARIFF RATES 67 6.2.3 DISRUPTION IN MICROBIAL INGREDIENTS INDUSTRY & POSTBIOTICS 67 6.2.4 PRICE IMPACT ANALYSIS 68 6.2.5 IMPACT ON COUNTRY/REGION 69 6.2.5.1 US 69 6.2.5.2 Europe 70 6.2.5.3 China 70 6.2.6 IMPACT ON END-USE INDUSTRIES 71 6.3 VALUE CHAIN ANALYSIS 72 6.3.1 RESEARCH & PRODUCT DEVELOPMENT 73 6.3.2 RAW MATERIAL SOURCING 73 6.3.3 PRODUCTION & PROCESSING 73 6.3.4 DISTRIBUTION 74 6.3.5 MARKETING & SALES 74 6.3.6 END USERS 74 6.4 TRADE ANALYSIS 74 6.4.1 IMPORT SCENARIO OF HS CODE 3002 74 6.4.2 EXPORT SCENARIO OF HS CODE 3002 76 6.5 TECHNOLOGY ANALYSIS 77 6.5.1 KEY TECHNOLOGIES 77 6.5.1.1 Heating-based inactivation technologies 77 6.5.1.2 Extraction technologies 77 6.5.1.3 Identification and characterization technologies 77 6.5.2 COMPLEMENTARY TECHNOLOGIES 78 6.5.2.1 Genomic and metabolomic profiling 78 6.5.2.2 Bioinformatics and machine learning 78 6.5.2.3 Bioprocess monitoring and automation 78 6.5.3 ADJACENT TECHNOLOGIES 78 6.5.3.1 Microbiome diagnostics: 16S rRNA sequencing 78 6.6 PRICING ANALYSIS 79 6.6.1 AVERAGE SELLING PRICE OF POSTBIOTIC PRODUCTS, BY KEY PLAYER 79 6.6.2 AVERAGE SELLING PRICE TREND, BY REGION 80 6.7 ECOSYSTEM ANALYSIS 81 6.7.1 DEMAND SIDE 81 6.7.2 SUPPLY SIDE 81 6.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 83 6.9 PATENT ANALYSIS 84 6.10 KEY CONFERENCES AND EVENTS, 2025–2026 86 6.11 REGULATORY LANDSCAPE 87 6.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 87 6.11.2 REGULATORY FRAMEWORK 88 6.11.2.1 North America 89 6.11.2.2 Europe 89 6.11.2.3 Asia Pacific 90 6.12 PORTER’S FIVE FORCES ANALYSIS 91 6.12.1 THREAT OF NEW ENTRANTS 92 6.12.2 THREAT OF SUBSTITUTES 92 6.12.3 BARGAINING POWER OF SUPPLIERS 93 6.12.4 BARGAINING POWER OF BUYERS 93 6.12.5 INTENSITY OF COMPETITIVE RIVALRY 93 6.13 KEY STAKEHOLDERS AND BUYING CRITERIA 93 6.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 93 6.13.2 BUYING CRITERIA 95 6.14 CASE STUDY ANALYSIS 96 6.14.1 DSM‑FIRMENICH’S STRATEGIC LEAP INTO POSTBIOTICS THROUGH ADARE BIOME ACQUISITION 96 6.14.2 ADM’S USD 30 MILLION INVESTMENT IN PROBIOTIC & POSTBIOTIC PRODUCTION FACILITY IN SPAIN 96 6.14.3 CARGILL’S ACQUISITION AND SCALE-UP OF EPICOR POSTBIOTIC INGREDIENT 97 6.15 INVESTMENT AND FUNDING SCENARIO 98 7 POSTBIOTICS MARKET, BY FUNCTION 99 7.1 INTRODUCTION 99 7.2 DIGESTIVE HEALTH 99 7.3 GUT HEALTH 100 7.4 IMMUNE HEALTH 100 7.5 SKIN HEALTH 101 7.6 HEART HEALTH 101 7.7 OTHER FUNCTIONS 102 8 POSTBIOTIC MARKET, BY MANUFACTURING TECHNOLOGY 103 8.1 INTRODUCTION 103 8.2 HEAT INACTIVATION 103 8.3 SPRAY DRYING 104 8.4 LYOPHILIZATION 104 8.5 OTHER MANUFACTURING TECHNOLOGIES 104   9 POSTBIOTICS MARKET, BY SOURCE 106 9.1 INTRODUCTION 107 9.2 BACTERIA 108 9.2.1 VERSATILITY AND WIDE-RANGING APPLICATIONS IN FUNCTIONAL FOOD, SUPPLEMENTS, AND THERAPEUTIC PRODUCTS TO DRIVE DEMAND 108 9.2.2 LACTOBACILLUS 111 9.2.3 BIFIDOBACTERIUM 111 9.2.4 OTHER BACTERIA 111 9.3 YEAST 111 9.3.1 RISING UTILIZATION IN ANIMAL HEALTHCARE AND FEED APPLICATIONS TO DRIVE MARKET 111 9.3.2 SACCHAROMYCES CEREVISIAE 113 9.3.3 SACCHAROMYCES BOULARDII 114 10 POSTBIOTICS MARKET, BY APPLICATION 115 10.1 INTRODUCTION 116 10.2 FUNCTIONAL FOOD & BEVERAGES 117 10.2.1 INCREASING FOCUS ON GUT AND IMMUNE HEALTH TO BOOST ADOPTION OF POSTBIOTIC INGREDIENTS 117 10.3 DIETARY SUPPLEMENTS 118 10.3.1 RISING EMPHASIS ON GUT AND IMMUNE HEALTH TO DRIVE DEMAND FOR POSTBIOTICS IN DIETARY SUPPLEMENTS 118 10.4 ANIMAL FEED 119 10.4.1 GROWING ADOPTION OF POSTBIOTICS IN ANIMAL FEED FOR IMPROVED HEALTH AND PERFORMANCE 119 10.5 COSMETICS & PERSONAL CARE 120 10.5.1 DEMAND FOR MICROBIOME-FRIENDLY FORMULATIONS IN COSMETICS & PERSONAL CARE TO DRIVE MARKET 120 10.6 PHARMACEUTICALS 121 10.6.1 THERAPEUTIC POTENTIAL TO DRIVE DEMAND FOR POSTBIOTICS IN PHARMACEUTICALS 121 11 POSTBIOTICS MARKET, BY FORM 123 11.1 INTRODUCTION 124 11.2 DRY 125 11.2.1 NEED FOR ENHANCED STABILITY, SHELF LIFE, AND APPLICATION FLEXIBILITY TO DRIVE DEMAND 125 11.3 LIQUID 126 11.3.1 EASE OF INCORPORATION INTO FUNCTIONAL BEVERAGES AND FERMENTED PRODUCTS TO DRIVE DEMAND 126   12 POSTBIOTICS MARKET, BY REGION 128 12.1 INTRODUCTION 129 12.2 NORTH AMERICA 131 12.2.1 US 135 12.2.1.1 Clinical innovation and evolving health needs to steer market trends 135 12.2.2 CANADA 137 12.2.2.1 Health Canada approvals and pediatric research to drive market 137 12.2.3 MEXICO 138 12.2.3.1 Rising interest in immune-supportive and gut-health formulations to drive market 138 12.3 EUROPE 140 12.3.1 GERMANY 143 12.3.1.1 Robust life sciences infrastructure and advanced industrial fermentation capabilities to drive market 143 12.3.2 UK 144 12.3.2.1 Growing interest in incorporating postbiotic ingredients into mainstream food and beverage products to boost market 144 12.3.3 FRANCE 146 12.3.3.1 Fermentation expertise and growing interest in scientifically backed microbial ingredients to drive market 146 12.3.4 ITALY 148 12.3.4.1 Increasing focus of key startups on fermentation technologies to drive market 148 12.3.5 SPAIN 149 12.3.5.1 Strategic investments in functional ingredient space to drive market 149 12.3.6 REST OF EUROPE 151 12.4 ASIA PACIFIC 153 12.4.1 CHINA 156 12.4.1.1 Growing consumer interest in gut health, functional foods, and wellness ingredients to drive market 156 12.4.2 JAPAN 158 12.4.2.1 Emphasis on gut health and functional nutrition to drive market 158 12.4.3 INDIA 159 12.4.3.1 Consumer shift toward functional and preventive nutrition products to drive market 159 12.4.4 AUSTRALIA & NEW ZEALAND 161 12.4.4.1 Increasing consumer demand for functional foods, clean-label ingredients, and gut health solutions to drive market 161 12.4.5 REST OF ASIA PACIFIC 162   12.5 REST OF THE WORLD 164 12.5.1 SOUTH AMERICA 167 12.5.1.1 Rising consumer awareness around gut health, immunity, and functional nutrition to drive market 167 12.5.2 MIDDLE EAST 169 12.5.2.1 Health and sustainability drives, including Vision 2030, to increase postbiotics adoption 169 12.5.3 AFRICA 170 12.5.3.1 Rising focus on gut health and preventive nutrition to drive market 170 13 COMPETITIVE LANDSCAPE 173 13.1 OVERVIEW 173 13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022–JULY 2025 173 13.3 REVENUE ANALYSIS, 2022–2024 175 13.4 MARKET SHARE ANALYSIS, 2024 176 13.5 COMPANY VALUATION AND FINANCIAL METRICS 179 13.6 BRAND/PRODUCT COMPARISON 180 13.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 181 13.7.1 STARS 181 13.7.2 EMERGING LEADERS 182 13.7.3 PERVASIVE PLAYERS 182 13.7.4 PARTICIPANTS 182 13.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 184 13.7.5.1 Company footprint 184 13.7.5.2 Regional footprint 184 13.7.5.3 Source footprint 185 13.7.5.4 Form footprint 186 13.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 186 13.8.1 PROGRESSIVE COMPANIES 186 13.8.2 RESPONSIVE COMPANIES 187 13.8.3 DYNAMIC COMPANIES 187 13.8.4 STARTING BLOCKS 187 13.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 189 13.8.5.1 Detailed list of key startups/SMEs 189 13.8.5.2 Competitive benchmarking of key startups/SMEs 190 13.9 COMPETITIVE SCENARIO 190 13.9.1 PRODUCT LAUNCHES 190 13.9.2 DEALS 191 13.9.3 EXPANSIONS 195   14 COMPANY PROFILES 197 14.1 KEY PLAYERS 197 14.1.1 ADM 197 14.1.1.1 Business overview 197 14.1.1.2 Products/Services/Solutions offered 198 14.1.1.3 Recent developments 199 14.1.1.3.1 Deals 199 14.1.1.3.2 Expansions 199 14.1.1.3.3 Other developments 200 14.1.1.4 MnM view 200 14.1.1.4.1 Key strengths 200 14.1.1.4.2 Strategic choices 200 14.1.1.4.3 Weaknesses & competitive threats 201 14.1.2 CARGILL, INCORPORATED 202 14.1.2.1 Business overview 202 14.1.2.2 Products/Services/Solutions offered 203 14.1.2.3 Recent developments 204 14.1.2.3.1 Deals 204 14.1.2.3.2 Expansions 205 14.1.2.3.3 Other developments 205 14.1.2.4 MnM view 206 14.1.2.4.1 Key strengths 206 14.1.2.4.2 Strategic choices 206 14.1.2.4.3 Weaknesses & competitive threats 206 14.1.3 DSM-FIRMENICH 207 14.1.3.1 Business overview 207 14.1.3.2 Products/Services/Solutions offered 208 14.1.3.3 Recent developments 209 14.1.3.3.1 Deals 209 14.1.3.4 MnM view 209 14.1.3.4.1 Key strengths 209 14.1.3.4.2 Strategic choices 210 14.1.3.4.3 Weaknesses & competitive threats 210 14.1.4 KERRY GROUP PLC 211 14.1.4.1 Business overview 211 14.1.4.2 Products/Services/Solutions offered 212 14.1.4.3 Recent developments 213 14.1.4.3.1 Product launches 213 14.1.4.3.2 Deals 213   14.1.4.4 MnM view 214 14.1.4.4.1 Key strengths 214 14.1.4.4.2 Strategic choices 214 14.1.4.4.3 Weaknesses & competitive threats 214 14.1.5 ASSOCIATED BRITISH FOODS PLC 215 14.1.5.1 Business overview 215 14.1.5.2 Products/Services/Solutions offered 216 14.1.5.3 Recent developments 217 14.1.5.3.1 Deals 217 14.1.5.4 MnM view 217 14.1.5.4.1 Key strengths 217 14.1.5.4.2 Strategic choices 218 14.1.5.4.3 Weaknesses & competitive threats 218 14.1.6 BASF 219 14.1.6.1 Business overview 219 14.1.6.2 Products/Services/Solutions offered 220 14.1.6.3 Recent developments 221 14.1.6.3.1 Product launches 221 14.1.6.4 MnM view 221 14.1.7 NOVONESIS GROUP 222 14.1.7.1 Business overview 222 14.1.7.2 Products/Services/Solutions offered 223 14.1.7.3 MnM view 224 14.1.8 INTERNATIONAL FLAVORS & FRAGRANCES INC. 225 14.1.8.1 Business overview 225 14.1.8.2 Products/Services/Solutions offered 226 14.1.8.3 MnM view 227 14.1.9 MCLS EUROPE B.V. 228 14.1.9.1 Business overview 228 14.1.9.2 Products/Services/Solutions offered 228 14.1.9.3 MnM view 228 14.1.10 PHILEO BY LESAFFRE 229 14.1.10.1 Business overview 229 14.1.10.2 Products/Services/Solutions offered 229 14.1.10.3 MnM view 230 14.1.11 LALLEMAND INC. 231 14.1.11.1 Business overview 231 14.1.11.2 Products/Services/Solutions offered 231 14.1.11.3 Recent developments 232 14.1.11.3.1 Deals 232 14.1.11.4 MnM view 232   14.1.12 SAMI-SABINSA GROUP 233 14.1.12.1 Business overview 233 14.1.12.2 Products/Services/Solutions offered 233 14.1.12.3 Recent developments 234 14.1.12.3.1 Deals 234 14.1.12.4 MnM view 234 14.1.13 CJ CHEILJEDANG CORP. 235 14.1.13.1 Business overview 235 14.1.13.2 Products/Services/Solutions offered 236 14.1.13.3 Recent developments 237 14.1.13.3.1 Product launches 237 14.1.13.3.2 Deals 237 14.1.13.4 MnM view 238 14.1.14 MORINAGA MILK INDUSTRY CO., LTD. 239 14.1.14.1 Business overview 239 14.1.14.2 Products/Services/Solutions offered 240 14.1.14.3 MnM view 240 14.1.15 KIRIN HOLDINGS COMPANY, LIMITED 241 14.1.15.1 Business overview 241 14.1.15.2 Products/Services/Solutions offered 242 14.1.15.3 Recent developments 242 14.1.15.3.1 Other developments 242 14.1.15.4 MnM view 243 14.2 OTHER PLAYERS 244 14.2.1 BIOTENOVA SDN. BHD. 244 14.2.1.1 Business overview 244 14.2.1.2 Products/Services/Solutions offered 244 14.2.1.3 Recent developments 245 14.2.1.3.1 Deals 245 14.2.1.4 MnM view 245 14.2.2 BIOPROX HEALTHCARE 246 14.2.2.1 Business overview 246 14.2.2.2 Products/Services/Solutions offered 246 14.2.2.3 MnM view 247 14.2.3 SILAB 248 14.2.3.1 Business overview 248 14.2.3.2 Products/Services/Solutions offered 248 14.2.3.3 Recent developments 249 14.2.3.3.1 Expansions 249 14.2.3.4 MnM view 249   14.2.4 PROBIONIC CORP. 250 14.2.4.1 Business overview 250 14.2.4.2 Products/Services/Solutions offered 250 14.2.4.3 MnM view 250 14.2.5 NUTRIGNOMIX SDN. BHD. 251 14.2.5.1 Business overview 251 14.2.5.2 Products/Services/Solutions offered 251 14.2.5.3 MnM view 252 14.2.6 STRATUM NUTRITION 253 14.2.7 BBT BIOTECH GMBH 253 14.2.8 VERDESIAN LIFE SCIENCES 254 14.2.9 SYNBIO TECH INC. 254 14.2.10 NEO CREMAR 255 15 ADJACENT & RELATED MARKETS 256 15.1 INTRODUCTION 256 15.2 STUDY LIMITATIONS 256 15.3 FUNCTIONAL FOOD INGREDIENTS MARKET 256 15.3.1 MARKET DEFINITION 256 15.3.2 MARKET OVERVIEW 257 15.4 PROBIOTICS MARKET 258 15.4.1 MARKET DEFINITION 258 15.4.2 MARKET OVERVIEW 258 16 APPENDIX 260 16.1 DISCUSSION GUIDE 260 16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 266 16.3 CUSTOMIZATION OPTIONS 268 16.4 RELATED REPORTS 268 16.5 AUTHOR DETAILS 269
圖表清單 List of Tables & Figures
TABLE 1 USD EXCHANGE RATES, 2020–2024 30 TABLE 2 POSTBIOTICS MARKET SNAPSHOT, 2025 VS. 2030 (USD MILLION) 41 TABLE 3 US ADJUSTED RECIPROCAL TARIFF RATES 67 TABLE 4 EXPECTED IMPACT LEVEL ON TARGET INGREDIENTS WITH RELEVANT HS CODES DUE TO US TARIFF IMPACT 69 TABLE 5 EXPECTED TARIFF IMPACT ON END-USE INDUSTRIES: POSTBIOTICS MARKET 71 TABLE 6 IMPORT SCENARIO FOR HS CODE: 3002, BY COUNTRY, 2020–2024 (TONS) 75 TABLE 7 EXPORT SCENARIO FOR HS CODE: 3002, BY COUNTRY, 2020–2024 (TONS) 76 TABLE 8 AVERAGE SELLING PRICE OF POSTBIOTIC PRODUCTS, BY KEY PLAYER, 2024 (USD) 80 TABLE 9 AVERAGE SELLING PRICE TREND OF POSTBIOTICS, BY REGION, 2021–2024 (USD/KG) 81 TABLE 10 POSTBIOTIC MARKET: ROLE OF COMPANIES IN ECOSYSTEM 82 TABLE 11 LIST OF MAJOR PATENTS PERTAINING TO POSTBIOTICS MARKET, 2022–2025 84 TABLE 12 POSTBIOTICS MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2025–2026 86 TABLE 13 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 87 TABLE 14 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 87 TABLE 15 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 88 TABLE 16 SOUTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 88 TABLE 17 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 88 TABLE 18 PORTER’S FIVE FORCES IMPACT ON POSTBIOTICS MARKET 91 TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY APPLICATIONS 94 TABLE 20 KEY CRITERIA FOR SELECTING SUPPLIERS/VENDORS 95 TABLE 21 POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION) 107 TABLE 22 POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 108 TABLE 23 POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (TONS) 108 TABLE 24 POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (TONS) 108 TABLE 25 BACTERIA: POSTBIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION) 109 TABLE 26 BACTERIA: POSTBIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION) 109 TABLE 27 BACTERIA: POSTBIOTICS MARKET, BY REGION, 2021–2024 (TONS) 110 TABLE 28 BACTERIA: POSTBIOTICS MARKET, BY REGION, 2025–2030 (TONS) 110 TABLE 29 BACTERIA: POSTBIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 110 TABLE 30 BACTERIA: POSTBIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 110 TABLE 31 YEAST: POSTBIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION) 112 TABLE 32 YEAST: POSTBIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION) 112 TABLE 33 YEAST: POSTBIOTICS MARKET, BY REGION, 2021–2024 (TONS) 112 TABLE 34 YEAST: POSTBIOTICS MARKET, BY REGION, 2025–2030 (TONS) 113 TABLE 35 YEAST: POSTBIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 113 TABLE 36 YEAST: POSTBIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 113 TABLE 37 POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 116 TABLE 38 POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 117 TABLE 39 FUNCTIONAL FOOD & BEVERAGES: POSTBIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION) 118 TABLE 40 FUNCTIONAL FOOD & BEVERAGES: POSTBIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION) 118 TABLE 41 DIETARY SUPPLEMENTS: POSTBIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION) 119 TABLE 42 DIETARY SUPPLEMENTS: POSTBIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION) 119 TABLE 43 ANIMAL FEED: POSTBIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION) 120 TABLE 44 ANIMAL FEED: POSTBIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION) 120 TABLE 45 COSMETICS & PERSONAL CARE: POSTBIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION) 121 TABLE 46 COSMETICS & PERSONAL CARE: POSTBIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION) 121 TABLE 47 PHARMACEUTICALS: POSTBIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION) 122 TABLE 48 PHARMACEUTICALS: POSTBIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION) 122 TABLE 49 POSTBIOTICS MARKET, BY FORM, 2021–2024 (USD MILLION) 124 TABLE 50 POSTBIOTICS MARKET, BY FORM, 2025–2030 (USD MILLION) 124 TABLE 51 DRY: POSTBIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION) 125 TABLE 52 DRY: POSTBIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION) 126 TABLE 53 LIQUID: POSTBIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION) 126 TABLE 54 LIQUID: POSTBIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION) 127 TABLE 55 POSTBIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION) 130 TABLE 56 POSTBIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION) 130 TABLE 57 POSTBIOTICS MARKET, BY REGION, 2021–2024 (TONS) 131 TABLE 58 POSTBIOTICS MARKET, BY REGION, 2025–2030 (TONS) 131 TABLE 59 NORTH AMERICA: POSTBIOTICS MARKET, BY COUNTRY, 2021–2024 (USD MILLION) 132 TABLE 60 NORTH AMERICA: POSTBIOTICS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 133 TABLE 61 NORTH AMERICA: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION) 133 TABLE 62 NORTH AMERICA: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 133 TABLE 63 NORTH AMERICA: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (TONS) 133 TABLE 64 NORTH AMERICA: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (TONS) 134 TABLE 65 NORTH AMERICA: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 134 TABLE 66 NORTH AMERICA: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 134 TABLE 67 NORTH AMERICA: POSTBIOTICS MARKET, BY FORM, 2021–2024 (USD MILLION) 134 TABLE 68 NORTH AMERICA: POSTBIOTICS MARKET, BY FORM, 2025–2030 (USD MILLION) 135 TABLE 69 US: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION) 135 TABLE 70 US: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 136 TABLE 71 US: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 136 TABLE 72 US: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 136 TABLE 73 CANADA: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION) 137 TABLE 74 CANADA: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 137 TABLE 75 CANADA: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 138 TABLE 76 CANADA: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 138 TABLE 77 MEXICO: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION) 139 TABLE 78 MEXICO: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 139 TABLE 79 MEXICO: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 139 TABLE 80 MEXICO: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 139 TABLE 81 EUROPE: POSTBIOTICS MARKET, BY COUNTRY, 2021–2024 (USD MILLION) 140 TABLE 82 EUROPE: POSTBIOTICS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 140 TABLE 83 EUROPE: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION) 141 TABLE 84 EUROPE: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 141 TABLE 85 EUROPE: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (TONS) 141 TABLE 86 EUROPE: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (TONS) 141 TABLE 87 EUROPE: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 142 TABLE 88 EUROPE: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 142 TABLE 89 EUROPE: POSTBIOTICS MARKET, BY FORM, 2021–2024 (USD MILLION) 142 TABLE 90 EUROPE: POSTBIOTICS MARKET, BY FORM, 2025–2030 (USD MILLION) 142 TABLE 91 GERMANY: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION) 143 TABLE 92 GERMANY: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 143 TABLE 93 GERMANY: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 144 TABLE 94 GERMANY: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 144 TABLE 95 UK: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION) 145 TABLE 96 UK: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 145 TABLE 97 UK: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 145 TABLE 98 UK: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 146 TABLE 99 FRANCE: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION) 146 TABLE 100 FRANCE: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 147 TABLE 101 FRANCE: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 147 TABLE 102 FRANCE: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 147 TABLE 103 ITALY: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION) 148 TABLE 104 ITALY: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 148 TABLE 105 ITALY: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 149 TABLE 106 ITALY: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 149 TABLE 107 SPAIN: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION) 150 TABLE 108 SPAIN: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 150 TABLE 109 SPAIN: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 150 TABLE 110 SPAIN: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 150 TABLE 111 REST OF EUROPE: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION) 151 TABLE 112 REST OF EUROPE: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 151 TABLE 113 REST OF EUROPE: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 152 TABLE 114 REST OF EUROPE: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 152 TABLE 115 ASIA PACIFIC: POSTBIOTICS MARKET, BY COUNTRY, 2021–2024 (USD MILLION) 154 TABLE 116 ASIA PACIFIC: POSTBIOTICS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 154 TABLE 117 ASIA PACIFIC: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION) 154 TABLE 118 ASIA PACIFIC: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 154 TABLE 119 ASIA PACIFIC: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (TONS) 155 TABLE 120 ASIA PACIFIC: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (TONS) 155 TABLE 121 ASIA PACIFIC: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 155 TABLE 122 ASIA PACIFIC: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 155 TABLE 123 ASIA PACIFIC: POSTBIOTICS MARKET, BY FORM, 2021–2024 (USD MILLION) 156 TABLE 124 ASIA PACIFIC: POSTBIOTICS MARKET, BY FORM, 2025–2030 (USD MILLION) 156 TABLE 125 CHINA: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION) 157 TABLE 126 CHINA: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 157 TABLE 127 CHINA: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 157 TABLE 128 CHINA: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 157 TABLE 129 JAPAN: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION) 158 TABLE 130 JAPAN: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 158 TABLE 131 JAPAN: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 159 TABLE 132 JAPAN: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 159 TABLE 133 INDIA: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION) 160 TABLE 134 INDIA: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 160 TABLE 135 INDIA: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 160 TABLE 136 INDIA: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 160 TABLE 137 AUSTRALIA & NEW ZEALAND: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION) 161 TABLE 138 AUSTRALIA & NEW ZEALAND: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 161 TABLE 139 AUSTRALIA & NEW ZEALAND: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 162 TABLE 140 AUSTRALIA & NEW ZEALAND: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 162 TABLE 141 REST OF ASIA PACIFIC: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION) 163 TABLE 142 REST OF ASIA PACIFIC: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 163 TABLE 143 REST OF ASIA PACIFIC: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 163 TABLE 144 REST OF ASIA PACIFIC: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 164 TABLE 145 REST OF THE WORLD: POSTBIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION) 164 TABLE 146 REST OF THE WORLD: POSTBIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION) 165 TABLE 147 REST OF THE WORLD: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION) 165 TABLE 148 REST OF THE WORLD: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 165 TABLE 149 REST OF THE WORLD: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (TONS) 165 TABLE 150 REST OF THE WORLD: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (TONS) 166 TABLE 151 REST OF THE WORLD: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 166 TABLE 152 REST OF THE WORLD: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 166 TABLE 153 REST OF THE WORLD: POSTBIOTICS MARKET, BY FORM, 2021–2024 (USD MILLION) 167 TABLE 154 REST OF THE WORLD: POSTBIOTICS MARKET, BY FORM, 2025–2030 (USD MILLION) 167 TABLE 155 SOUTH AMERICA: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION) 168 TABLE 156 SOUTH AMERICA: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 168 TABLE 157 SOUTH AMERICA: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 168 TABLE 158 SOUTH AMERICA: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 168 TABLE 159 MIDDLE EAST: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION) 169 TABLE 160 MIDDLE EAST: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 169 TABLE 161 MIDDLE EAST: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 170 TABLE 162 MIDDLE EAST: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 170 TABLE 163 AFRICA: POSTBIOTICS MARKET, BY SOURCE, 2021–2024 (USD MILLION) 171 TABLE 164 AFRICA: POSTBIOTICS MARKET, BY SOURCE, 2025–2030 (USD MILLION) 171 TABLE 165 AFRICA: POSTBIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 171 TABLE 166 AFRICA: POSTBIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 172 TABLE 167 OVERVIEW OF STRATEGIES ADOPTED BY KEY POSTBIOTICS MARKET PLAYERS, 2022–JULY 2025 174 TABLE 168 PLANT-BASED PROTEIN MARKET: MARKET SHARE ANALYSIS, 2024 177 TABLE 169 POSTBIOTICS MARKET: REGIONAL FOOTPRINT 184 TABLE 170 POSTBIOTICS MARKET: SOURCE FOOTPRINT 185 TABLE 171 POSTBIOTICS MARKET: FORM FOOTPRINT 186 TABLE 172 POSTBIOTICS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 189 TABLE 173 POSTBIOTICS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 190 TABLE 174 POSTBIOTICS MARKET: PRODUCT LAUNCHES, JUNE 2022–MARCH 2025 190 TABLE 175 POSTBIOTICS MARKET: DEALS, DECEMBER 2022–FEBRUARY 2025 191 TABLE 176 POSTBIOTICS MARKET: EXPANSIONS, FEBRUARY 2020–NOVEMBER 2024 195 TABLE 177 ADM: COMPANY OVERVIEW 197 TABLE 178 ADM: PRODUCTS/SERVICES/SOLUTIONS OFFERED 198 TABLE 179 ADM: DEALS 199 TABLE 180 ADM: EXPANSIONS 199 TABLE 181 ADM: OTHER DEVELOPMENTS 200 TABLE 182 CARGILL, INCORPORATED: COMPANY OVERVIEW 202 TABLE 183 CARGILL, INCORPORATED: PRODUCTS/SERVICES/SOLUTIONS OFFERED 203 TABLE 184 CARGILL, INCORPORATED: DEALS 204 TABLE 185 CARGILL, INCORPORATED: EXPANSIONS 205 TABLE 186 CARGILL, INCORPORATED: OTHER DEVELOPMENTS 205 TABLE 187 DSM-FIRMENICH: COMPANY OVERVIEW 207 TABLE 188 DSM-FIRMENICH: PRODUCTS/SERVICES/SOLUTIONS OFFERED 208 TABLE 189 DSM-FIRMENICH: DEALS 209 TABLE 190 KERRY GROUP PLC: COMPANY OVERVIEW 211 TABLE 191 KERRY GROUP PLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED 212 TABLE 192 KERRY GROUP PLC: PRODUCT LAUNCHES 213 TABLE 193 KERRY GROUP PLC: DEALS 213 TABLE 194 ASSOCIATED BRITISH FOODS PLC: COMPANY OVERVIEW 215 TABLE 195 ASSOCIATED BRITISH FOODS PLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED 216 TABLE 196 ASSOCIATED BRITISH FOODS PLC: DEALS 217 TABLE 197 BASF: COMPANY OVERVIEW 219 TABLE 198 BASF: PRODUCTS/SERVICES/SOLUTIONS OFFERED 220 TABLE 199 BASF: PRODUCT LAUNCHES 221 TABLE 200 NOVONESIS GROUP: COMPANY OVERVIEW 222 TABLE 201 NOVONESIS GROUP: PRODUCTS/SERVICES/SOLUTIONS OFFERED 223 TABLE 202 INTERNATIONAL FLAVORS & FRAGRANCES INC.: COMPANY OVERVIEW 225 TABLE 203 INTERNATIONAL FLAVORS & FRAGRANCES INC.: PRODUCTS/SERVICES/ SOLUTIONS OFFERED 226 TABLE 204 MCLS EUROPE B.V.: COMPANY OVERVIEW 228 TABLE 205 MCLS EUROPE B.V.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 228 TABLE 206 PHILEO BY LESAFFRE: COMPANY OVERVIEW 229 TABLE 207 PHILEO BY LESAFFRE: PRODUCTS/SERVICES/SOLUTIONS OFFERED 229 TABLE 208 LALLEMAND INC.: COMPANY OVERVIEW 231 TABLE 209 LALLEMAND INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 231 TABLE 210 LALLEMAND INC.: DEALS 232 TABLE 211 SAMI-SABINSA GROUP: COMPANY OVERVIEW 233 TABLE 212 SAMI-SABINSA GROUP: PRODUCTS/SERVICES/SOLUTIONS OFFERED 233 TABLE 213 SAMI-SABINSA GROUP: DEALS 234 TABLE 214 CJ CHEILJEDANG CORP.: COMPANY OVERVIEW 235 TABLE 215 CJ CHEILJEDANG CORP.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 236 TABLE 216 CJ CHEILJEDANG CORP.: PRODUCT LAUNCHES 237 TABLE 217 CJ CHEILJEDANG CORP.: DEALS 237 TABLE 218 MORINAGA MILK INDUSTRY CO., LTD.: COMPANY OVERVIEW 239 TABLE 219 MORINAGA MILK INDUSTRY CO., LTD.: PRODUCTS/SERVICES/ SOLUTIONS OFFERED 240 TABLE 220 KIRIN HOLDINGS COMPANY, LIMITED: COMPANY OVERVIEW 241 TABLE 221 KIRIN HOLDINGS COMPANY, LIMITED: PRODUCTS/SERVICES/ SOLUTIONS OFFERED 242 TABLE 222 KIRIN HOLDINGS COMPANY, LIMITED: OTHER DEVELOPMENTS 242 TABLE 223 BIOTENOVA SDN. BHD.: COMPANY OVERVIEW 244 TABLE 224 BIOTENOVA SDN. BHD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 244 TABLE 225 BIOTENOVA SDN. BHD.: DEALS 245 TABLE 226 BIOPROX HEALTHCARE: COMPANY OVERVIEW 246 TABLE 227 BIOPROX HEALTHCARE: PRODUCTS/SERVICES/SOLUTIONS OFFERED 246 TABLE 228 SILAB: COMPANY OVERVIEW 248 TABLE 229 SILAB: PRODUCTS/SERVICES/SOLUTIONS OFFERED 248 TABLE 230 SILAB: EXPANSIONS 249 TABLE 231 PROBIONIC CORP.: COMPANY OVERVIEW 250 TABLE 232 PROBIONIC CORP.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 250 TABLE 233 NUTRIGNOMIX SDN. BHD.: COMPANY OVERVIEW 251 TABLE 234 NUTRIGNOMIX SDN. BHD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 251 TABLE 235 MARKETS ADJACENT TO POSTBIOTICS MARKET 256 TABLE 236 FUNCTIONAL FOOD INGREDIENTS MARKET, BY SOURCE, 2019–2023 (USD MILLION) 257 TABLE 237 FUNCTIONAL FOOD INGREDIENTS MARKET, BY SOURCE, 2024–2029 (USD MILLION) 257 TABLE 238 PROBIOTICS MARKET, BY END USER, 2020–2023 (USD BILLION) 259 TABLE 239 PROBIOTICS MARKET, BY END USER, 2024–2029 (USD BILLION) 259 FIGURE 1 POSTBIOTICS MARKET: RESEARCH DESIGN 31 FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 33 FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 35 FIGURE 4 SUPPLY-SIDE ANALYSIS: SOURCES OF INFORMATION AT EVERY STEP 36 FIGURE 5 POSTBIOTICS MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 37 FIGURE 6 DATA TRIANGULATION 38 FIGURE 7 POSTBIOTICS MARKET, BY SOURCE, 2025 VS. 2030 (USD MILLION) 42 FIGURE 8 POSTBIOTICS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 43 FIGURE 9 POSTBIOTICS MARKET, BY FORM, 2025 VS. 2030 (USD MILLION) 43 FIGURE 10 POSTBIOTICS MARKET SHARE AND GROWTH RATE, BY REGION 44 FIGURE 11 INCREASING DEMAND FOR FORTIFIED AND HEALTH-POSITIONED FOODS AND BEVERAGES TO DRIVE MARKET 45 FIGURE 12 US AND BACTERIA SEGMENT TO ACCOUNT FOR SIGNIFICANT MARKET SHARES IN 2025 46 FIGURE 13 BACTERIA SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 46 FIGURE 14 DRY SEGMENT TO LEAD MARKET DURING FORECAST PERIOD 47 FIGURE 15 FUNCTIONAL FOOD & BEVERAGES SEGMENT TO LEAD MARKET DURING FORECAST PERIOD 47 FIGURE 16 US TO RECORD LARGEST MARKET SHARE IN 2025 48 FIGURE 17 POSTBIOTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 52 FIGURE 18 ADOPTION OF GEN AI IN FOOD & BEVERAGE PRODUCTION PROCESS 61 FIGURE 19 POSTBIOTICS MARKET: VALUE CHAIN ANALYSIS 72 FIGURE 20 IMPORT OF HS CODE 3002, BY KEY COUNTRY, 2020–2024 (TONS) 75 FIGURE 21 EXPORT OF HS CODE 3002, BY KEY COUNTRY, 2020–2024 (TONS) 76 FIGURE 22 AVERAGE SELLING PRICE OF POSTBIOTIC PRODUCTS, BY KEY PLAYER, 2024 (USD) 79 FIGURE 23 AVERAGE SELLING PRICE TREND OF POSTBIOTICS, BY REGION, 2021–2024 (USD/KG) 80 FIGURE 24 POSTBIOTIC MARKET: ECOSYSTEM ANALYSIS 82 FIGURE 25 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 83 FIGURE 26 NUMBER OF PATENTS APPLIED AND GRANTED, 2017–2025 85 FIGURE 27 REGIONAL ANALYSIS OF PATENTS GRANTED FOR POSTBIOTICS 86 FIGURE 28 POSTBIOTICS MARKET: PORTER’S FIVE FORCES ANALYSIS 92 FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY APPLICATIONS 94 FIGURE 30 KEY CRITERIA FOR SELECTING SUPPLIERS/VENDORS 95 FIGURE 31 POSTBIOTIC MARKET: INVESTMENT AND FUNDING SCENARIO 98 FIGURE 32 POSTBIOTICS MARKET, BY SOURCE, 2025 VS. 2030 (USD MILLION) 107 FIGURE 33 POSTBIOTICS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 116 FIGURE 34 POSTBIOTICS MARKET, BY FORM, 2025 VS. 2030 (USD MILLION) 124 FIGURE 35 INDIA TO RECORD HIGHEST GROWTH DURING FORECAST PERIOD 130 FIGURE 36 NORTH AMERICA: POSTBIOTICS MARKET SNAPSHOT 132 FIGURE 37 ASIA PACIFIC: POSTBIOTICS MARKET SNAPSHOT 153 FIGURE 38 REVENUE ANALYSIS OF KEY MARKET PLAYERS, 2022–2024 (USD BILLION) 175 FIGURE 39 MARKET SHARE ANALYSIS, 2024 177 FIGURE 40 COMPANY VALUATION 179 FIGURE 41 FINANCIAL METRICS 179 FIGURE 42 POSTBIOTICS MARKET: BRAND/PRODUCT COMPARISON 180 FIGURE 43 POSTBIOTICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 183 FIGURE 44 POSTBIOTICS MARKET: COMPANY FOOTPRINT 184 FIGURE 45 POSTBIOTICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 188 FIGURE 46 ADM: COMPANY SNAPSHOT 198 FIGURE 47 CARGILL, INCORPORATED: COMPANY SNAPSHOT 203 FIGURE 48 DSM-FIRMENICH: COMPANY SNAPSHOT 208 FIGURE 49 KERRY GROUP PLC: COMPANY SNAPSHOT 212 FIGURE 50 ASSOCIATED BRITISH FOODS PLC: COMPANY SNAPSHOT 216 FIGURE 51 BASF: COMPANY SNAPSHOT 220 FIGURE 52 NOVONESIS GROUP: COMPANY SNAPSHOT 223 FIGURE 53 INTERNATIONAL FLAVORS & FRAGRANCES INC.: COMPANY SNAPSHOT 226 FIGURE 54 CJ CHEILJEDANG CORP.: COMPANY SNAPSHOT 236 FIGURE 55 MORINAGA MILK INDUSTRY CO., LTD.: COMPANY SNAPSHOT 240 FIGURE 56 KIRIN HOLDINGS COMPANY, LIMITED: COMPANY SNAPSHOT 242

同分類最新報告（食品與飲料）

查看食品與飲料全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們